HEALTH● LOWAug 26 · Aug 26, 2026, 11:09 PM
FDA approves new drug Rasonque to treat advanced pancreatic cancer
France 24 [en]
The US FDA on Wednesday approved Revolution Medicines' Rasonque for advanced pancreatic cancer, opening a new treatment option for patients with metastatic disease. A large trial found the once-daily pill doubled survival rates, offering fresh hope for people who have exhausted other treatments.
GlobeAlert aggregates and classifies open sources; the story above belongs to its publisher. Summaries are machine-generated from the source text.
More in Health
HEALTH31m agoEbola: Kano govt activates emergency operatiions centreVanguard NigeriaHEALTH32m agoUganda Debunks Claims Of Ebola Outbreak After Nigeria Confirmed InfectionChannels TVHEALTH33m agoJennifer Gil, nurse and midwife specialized in fertility and hormonal health: “Folic acid does not help get pregnant, but it does prevent alterations in the formation of the baby in the first weeks of gestation”ClarínHEALTH35m agoPsychology says that members of Generation X and Baby Boomers who are in bed by 10 PM have generally already learned 8 life lessonsClarín